City

Baltimore (1)

Boston (1)

Charleston (1)

Memphis (1)

Milwaukee (1)

St. Louis (1)

Washington (1)

Condition

Sickle Cell Disease (2)

Cardiovascular Diseases (1)

Coronary Artery Disease (1)

Overall Status

Completed (2)

Not yet recruiting (1)

Phase

phase 2 (2)

phase 1 (1)

Sponsor

Dana-Farber Cancer Institute (1)

Medical University of South Carolina (1)

St. Jude Children's Research Hospital (1)

Collaborator

Astellas Pharma Global Development, Inc. (1)

Astellas Pharma US, Inc. (1)

Boston Children's Hospital (1)

Brigham and Women's Hospital (1)

Johns Hopkins University (1)

La Jolla Institute for Allergy & Immunology (1)

Medical College of Wisconsin (1)

National Heart, Lung, and Blood Institute (NHLBI) (1)

Washington University School of Medicine (1)

Intervention

lexiscan (3)

[13n]nh3 (1)

positron emission tomography (1)

Study Documents

Intervention Type

drug (3)

diagnostic test (1)

Funder Type

Other (3)

Study Type

Interventional (3)

lexiscan

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Sickle Cell Disease Trial in Memphis ([13N]NH3, Lexiscan, Positron emission tomography)

Not yet recruiting

Sickle Cell Disease

[13N]NH3
+2 more

Memphis, Tennessee

St. Jude Children's Research Hospital

Jan 11, 2023

Cardiovascular Diseases, Coronary Artery Disease Trial in Charleston (Lexiscan)

Completed

Has Results

Cardiovascular Diseases
Coronary Artery Disease

Lexiscan

Charleston, South Carolina

Medical University of South Carolina

Jul 18, 2019

Sickle Cell Disease Trial in United States (Lexiscan)

Completed

Has Results

Sickle Cell Disease

Lexiscan

Washington, District of Columbia
+6 more

Feb 5, 2014